Case study: cytochrome P450 and drug metabolism
A handful of liver enzymes, the cytochrome P450 family, metabolize most of the drugs you will ever take; one of them, CYP3A4, handles about half. When two drugs compete for the same P450, or one switches it off, the other can build up to dangerous levels: the source of many drug–drug interactions. P450s do their chemistry with an iron atom held in a heme ring, passing through high-valent iron–oxo states whose spin configurations are delicate. They are a natural test case for quantum computing in pharmacology.
On the plate: where a quantum computer would overtake classical methods for P450 models.
The chemistry and the difficulty
P450 activates molecular oxygen and inserts one oxygen atom into a carbon–hydrogen bond of the drug, making it more water-soluble so the body can excrete it. The key intermediate, “compound I”, an iron(IV)–oxo with a radical spread over the heme ring, has nearly degenerate spin states, and which spin surface the reaction follows (the “two-state reactivity” proposed by Sason Shaik and colleagues) affects rates and products. Different density functionals disagree on spin-state energy gaps by many kcal/mol, which is exactly the regime where multireference methods, and eventually quantum computers, are needed. Established as a hard problem.
The advantage frontier
In 2022 Joshua Goings and colleagues at Google and Boehringer Ingelheim built a ladder of P450 active-space models of increasing size, solved the small ones with classical methods, and estimated quantum resources for the large ones, to locate where a fault-tolerant quantum computer would beat the best classical heuristics. The plate shows a schematic of that comparison: classical cost rising exponentially with active-space size at rate 0.25 decades per orbital, against a quantum cost that grows polynomially but starts high, here seconds. The crossover moves sharply with assumptions about classical growth, which is why the frontier is uncertain: better classical heuristics push it right. Their conclusion was that quantum advantage for such problems is plausible at active spaces beyond what classical methods can handle reliably, with error-corrected machines of millions of physical qubits. Speculative
The critique
Predicting drug metabolism in practice depends on much more than the energy of compound I: which drug binds, in which orientation, how often, which site is oxidized, and how fast the products leave. Machine-learning models trained on metabolism data already predict likely sites of metabolism reasonably well. A quantum computer could sharpen the electronic-structure step, the spin-state energetics, but its value to drug development depends on the whole workflow, and on whether that step is the bottleneck for a given question. Speculative
What you now have
Why P450s matter for drug interactions, compound I and two-state reactivity, why DFT is unreliable for its spin states, the Goings et al. advantage-frontier study, and why the workflow, not one energy, determines value.
· · ·
Three questions to carry with you.
And one to work out. Classical time is seconds for orbitals; quantum time is seconds. At what do they cross?
Sources: F. P. Guengerich, Chem. Res. Toxicol. 14, 611 (2001). S. Shaik et al., Chem. Rev. 110, 949 (2010). J. J. Goings et al., Proc. Natl Acad. Sci. USA 119, e2203533119 (2022). The frontier plot is a schematic with adjustable assumptions, not Goings et al.’s data.